Paradox

One does not simply invest in biotech

And yet, many people are passionate about biotech, investing, and longevity — probably you too, if you're reading this. But investing in this sector remains challenging, especially for the general public. Buying stocks or complex financial products and then waiting — perhaps for years — simply isn't attractive enough.

So, what remains for patients and their families? What hope is left? Sadly, very little. This is UNFAIR !